Research output: Contribution to journal › Article › peer-review
Glioblastoma MRI Dataset with Standardized Preprocessing, Expert-Validated Segmentation, and MGMT Profiling. / Тучинов, Баир Николаевич; Шакур, Ахсан ; Бенедичук, Маргарита Вячеславовна et al.
In: Scientific Data, Vol. 13, 1213, 07.08.2026.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Glioblastoma MRI Dataset with Standardized Preprocessing, Expert-Validated Segmentation, and MGMT Profiling
AU - Тучинов, Баир Николаевич
AU - Шакур, Ахсан
AU - Бенедичук, Маргарита Вячеславовна
AU - Филимонова, Елена Андреевна
AU - Рзаев, Джамиль Афет Оглы
AU - Щукина, Мария Игоревна
AU - Лыу, Минь Шао Кхуэ
AU - Leone, Augusto
AU - Carbone, Francesco
AU - Zoli, Matteo
AU - Carretta, Alessandro
AU - Bianconi, Andrea
AU - Cofano, Fabio
AU - Morello, Alberto
AU - Armocida, Daniele
AU - Spetzger, Uwe
AU - Roumia, Safwan
AU - Di Napoli, Veronica
AU - Pio Fochi, Nicola
AU - Lau, Ruth
AU - Internо, Valeria
AU - Giordano, Guido
AU - Curcio, Antonello
AU - Rustici, Arianna
AU - Angileri, Flavio
AU - Mazzatenta, Diego
AU - Signorelli, Francesco
AU - Porta, Camillo
AU - Garbossa, Diego
AU - Colamaria, Antonio
N1 - Filimonova, E., Leone, A., Carbone, F. et al. Glioblastoma MRI Dataset with Standardized Preprocessing, Expert-Validated Segmentation, and MGMT Profiling. Sci Data 13, 1213 (2026). https://doi.org/10.1038/s41597-026-07953-2 This research was supported by a grant for research centers, provided by the Ministry of Economic Development of the Russian Federation in accordance with the subsidy agreement with the Novosibirsk State University dated 17 April 2025 No. 139-15-2025-006: IGK 000000C313925P3S0002
PY - 2026/8/7
Y1 - 2026/8/7
N2 - Glioblastoma research increasingly relies on large, well-curated imaging datasets that combine standardized MRI data, accurate tumor segmentations, and molecular profiling. We constructed a multi-center dataset of preoperative MRI scans from 337 patients with histologically confirmed primary glioblastoma collected across eight hospitals. All cases include T1-weighted (pre- and post-contrast), T2-weighted, and FLAIR sequences. Images underwent systematic quality assessment, BIDS organization, defacing, skull stripping, and linear registration to the MNI152 template. Tumor segmentation was performed using a SegResNet CNN model following the BraTS labeling convention, with all masks reviewed and manually refined by neuroradiologists. MGMT promoter methylation status was determined for all patients. This dataset provides a robust, clinically representative resource for radiomics, deep learning, and radiogenomic research in glioblastoma, supporting concrete downstream tasks including automated segmentation benchmarking (mean Dice = 0.94) and MGMT methylation prediction (baseline ACC = 0.60). Its multi-center origin, comprehensive preprocessing, expert-refined segmentations, and complete MGMT annotations address limitations of existing datasets and support the development and validation of reproducible imaging biomarkers.
AB - Glioblastoma research increasingly relies on large, well-curated imaging datasets that combine standardized MRI data, accurate tumor segmentations, and molecular profiling. We constructed a multi-center dataset of preoperative MRI scans from 337 patients with histologically confirmed primary glioblastoma collected across eight hospitals. All cases include T1-weighted (pre- and post-contrast), T2-weighted, and FLAIR sequences. Images underwent systematic quality assessment, BIDS organization, defacing, skull stripping, and linear registration to the MNI152 template. Tumor segmentation was performed using a SegResNet CNN model following the BraTS labeling convention, with all masks reviewed and manually refined by neuroradiologists. MGMT promoter methylation status was determined for all patients. This dataset provides a robust, clinically representative resource for radiomics, deep learning, and radiogenomic research in glioblastoma, supporting concrete downstream tasks including automated segmentation benchmarking (mean Dice = 0.94) and MGMT methylation prediction (baseline ACC = 0.60). Its multi-center origin, comprehensive preprocessing, expert-refined segmentations, and complete MGMT annotations address limitations of existing datasets and support the development and validation of reproducible imaging biomarkers.
UR - https://www.scopus.com/pages/publications/105047924963
U2 - https://doi.org/10.1038/s41597-026-07953-2
DO - https://doi.org/10.1038/s41597-026-07953-2
M3 - Article
C2 - 42629349
VL - 13
JO - Scientific Data
JF - Scientific Data
SN - 2052-4463
M1 - 1213
ER -
ID: 82778615